STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway
Oncology Research · 2025
DOI: 10.32604/or.2024.048562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Lei Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Jen Ching Memorial Hospital, Suzhou, 215300, China. Hauptthemen laut MEDLINE: Glycolysis, Adenocarcinoma of Lung, E2F1 Transcription Factor, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
To investigate SCL/TAL 1 interrupting locus (STIL)'s role and prognostic significance in lung adenocarcinoma (LUAD) progression, we examined STIL and E2 promoter binding factor 1 (E2F1) expression and their impacts on LUAD prognosis using Gene Expression Profiling Interactive Analysis (GEPIA).
Methods
Functional assays including CCK-8, wound-healing, 5-ethynyl-2-deoxyuridine (EdU), Transwell assays, and flow cytometry, elucidated STIL and E2F1's effects on cell viability, proliferation, apoptosis, and migration. Gene set enrichment analysis (GSEA) identified potential pathways, while metabolic assays assessed glucose metabolism.
Results
Our findings reveal that STIL and E2F1 are overexpressed in LUAD, correlating with adverse outcomes. It enhances cell proliferation, migration, and invasion, and suppresses apoptosis, activating downstream of E2F1. Silencing E2F1 reversed the promotion effect of the STIL overexpression on cell viability and invasiveness. Importantly, STIL modulates glycolysis, influencing glucose consumption, lactate production, and energy balance in LUAD cells.
Conclusion
Our model, incorporating STIL, age, and disease stage, robustly predicts patient prognosis, underscored STIL's pivotal role in LUAD pathogenesis through metabolic reprogramming. This comprehensive approach not only confirms STIL's prognostic value but also highlights its potential as a therapeutic target in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Jen Ching Memorial Hospital, Suzhou, 215300, China.
- Department of Respiratory Medicine, Shandong Provincial Third Hospital, Jinan, 250010, China.
Zitieren
APA
Wang, L., & Xie, X. (2025). STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway. Oncology Research. https://doi.org/10.32604/or.2024.048562
Vancouver
Wang L, Xie X. STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway. Oncology Research. 2025. doi:10.32604/or.2024.048562
BibTeX
@article{Wang2025,
author = {Wang, Lei and Xie, Xianjin},
title = {STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2024.048562}
}
EUVIMED